info icon

Malignant neoplasm of breast, HER-positive

C3_BREAST_ERPLUS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

  • RX_ERPLUS
15625

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C50
  • Cause of death: ICD-9 174
  • Cause of death: ICD-8 174
  • Cancer registry: Topography ICD-O-3 C50
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes [23]

2 out of 7 registries used, show all original rules.

14782

4. Check minimum number of events

None

14782

5. Include endpoints

None

14782

6. Filter based on genotype QC (FinnGen only)

14782

Control definitions (FinnGen only)

Control conditions
not RX_ERPLUS

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF9

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 14782 14782 -
Unadjusted period prevalence (%) 5.04 5.04 -
Median age at first event (years) 60.07 60.07 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
12439
Matched controls
124295
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
28.7
323.0
1362
529
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
28.4
323.0
4771
2664
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
27.7
323.0
1131
447
192
Kela drug reimbursment
Fulvestrant
+∞
323.0
529
*
PJW99
NOMESCO Finland
Other operation on lymphatic system
55.5
323.0
419
78
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
26.1
323.0
1303
555
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
18.7
323.0
2460
1615
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
26.3
323.0
3908
2127
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
49.0
323.0
1699
400
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
20.8
323.0
1803
1005
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.4
323.0
1429
481
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
18.7
323.0
1585
962
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
18.7
323.0
1971
1241
HAB99
NOMESCO Finland
Other partial excision of mammary gland
14.3
323.0
1643
1309
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.3
323.0
5102
17419
JN4BD
NOMESCO Finland
Extensive body CT
4.5
323.0
2503
6555
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
38.5
323.0
1507
443
1501
Kela drug reimbursment
Palbociclib
475.7
323.0
549
12
Z31.5
ICD-10 Finland
Genetic counselling
6.3
323.0
1424
2485
L02BG03
ATC
anastrozole; oral
619.8
323.0
2080
40
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
28.5
323.0
1865
764
L03AA13
ATC
pegfilgrastim; parenteral
20.1
323.0
2608
1618
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
47.9
323.0
1491
353
L02BA01
ATC
tamoxifen; oral
587.2
323.0
6080
202
C50.99
ICD-10 Finland
Breast, unspecified
25.3
323.0
2470
1204
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
24.2
323.0
3809
2227
A03FA01
ATC
metoclopramide; systemic, rectal
8.3
323.0
7160
17531
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
29.1
323.0
1257
478
WF003
NOMESCO Finland
Adjuvant radiotherapy
12.6
323.0
1661
1507
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
39.3
323.0
462
122
N63
ICD-10 Finland
Unspecified lump in breast
4.4
323.0
1865
4777
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
25.3
323.0
1179
513
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
27.1
323.0
1976
859
XX3DW
NOMESCO Finland
Time consuming IT work
6.9
323.0
3220
5952
M05BX04
ATC
denosumab; parenteral
4.1
323.0
1393
3712
A04AA55
ATC
palonosetron, combinations; systemic
21.2
323.0
2224
1265
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
12.6
323.0
861
732
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
16.4
323.0
575
366
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
31.6
323.0
466
153
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
27.3
323.0
603
231
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
84.1
323.0
758
96
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
51.8
323.0
4264
1237
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
31.4
323.0
2069
786
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
28.9
323.0
728
267
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
25.5
323.0
1377
603
ZX080
NOMESCO Finland
Image guided radiotherapy
16.6
323.0
1142
751
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
34.1
323.0
1991
690
X76
ICPC
Malignant neoplasm breast female
40.0
323.0
1879
550
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
21.1
323.0
675
337
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
11.7
323.0
838
761
L02BG06
ATC
exemestane; oral
548.3
323.0
1797
38
A04AA02
ATC
granisetron; systemic, transdermal
15.6
323.0
3343
2860
HAE99
NOMESCO Finland
Other reconstruction of breast
20.0
323.0
528
275
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
23.8
323.0
1682
811
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
20.0
323.0
2585
1613
C50
ICD-10 Finland
Malignant neoplasm of breast
27.3
323.0
2087
912
XX1XN
NOMESCO Finland
Other isotope examination
17.3
323.0
549
331
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
24.1
323.0
1392
646
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.5
323.0
1440
2455
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.8
323.0
6471
27497
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
41.9
323.0
1331
354
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
25.4
323.0
5678
3977
HAB40
NOMESCO Finland
Wedge excision of mammary gland
25.2
323.0
4782
2999
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
12.9
323.0
718
587
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
48.3
323.0
6475
2728
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
57.3
323.0
606
111
394
Kela drug reimbursment
Palbociclib
387.4
323.0
488
13
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
34.2
323.0
509
155
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
16.1
323.0
1113
754
1CD02
NOMESCO Finland
NA
61.2
323.0
695
120
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
17.0
323.0
723
449
115
Kela drug reimbursment
Breast cancer
7176.9
323.0
12347
2132
A04AA01
ATC
ondansetron; systemic, rectal
4.0
323.0
1612
4474
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
26.2
323.0
2837
1388
WZC30
NOMESCO Finland
Teaching
3.1
323.0
2411
8950
L02BG04
ATC
letrozole; oral
282.6
323.0
8193
844
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
190.4
323.0
3358
241
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.9
323.0
9268
37141
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
17.0
323.0
739
460
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
27.2
323.0
1258
512
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
24.3
323.0
876
387
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
323.0
5531
33941
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.5
323.0
3185
4328
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
21.9
323.0
3450
2143
ZX120
NOMESCO Finland
Intravenous
4.1
323.0
2106
5842
L02BA03
ATC
fulvestrant; parenteral
+∞
323.0
560
*
R4110
NOMESCO Finland
Physiotherapy
2.5
323.0
4424
22651
A04AD12
ATC
aprepitant; systemic
24.3
323.0
1441
668
HA1AA
NOMESCO Finland
X-ray mammography
26.3
323.0
6540
5027
H02AB02
ATC
dexamethasone; systemic
18.8
323.0
5936
5759
ZX090
NOMESCO Finland
Other technic of radiotherapy
14.8
323.0
1293
967
TQW20
NOMESCO Finland
Tatoe
28.5
323.0
952
360
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
86.1
323.0
496
60
L03AA14
ATC
lipegfilgrastim; parenteral
14.3
323.0
1026
774
L01XE33
ATC
[U] palbociclib; oral
1028.4
323.0
399
*
PJA12
NOMESCO Finland
Sentinel node biopsy
47.2
323.0
7790
4260
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
19.7
323.0
681
365
HAC20
NOMESCO Finland
Total mastectomy
44.8
323.0
4588
1599
ZZF00
NOMESCO Finland
Graft of adipose tissue
18.4
317.0
503
284
ZZR10
NOMESCO Finland
Flap of skin and muscle
19.6
315.2
489
259
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
22.5
315.1
467
215
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
53.7
312.1
376
72
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
11.9
308.5
587
513
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
23.8
303.5
442
192
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
35.8
303.0
396
114
TQB05
NOMESCO Finland
Puncture of skin of trunk
19.0
302.5
474
258
ZX112
NOMESCO Finland
Subcutaneous
9.2
300.9
658
749
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.7
297.2
803
1267
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
13.5
295.9
531
408
L01EF01
ATC
palbociclib; oral
593.5
294.2
291
5
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.3
291.5
597
603
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
25.0
289.4
415
171
Z51.0
ICD-10 Finland
Radiotherapy session
15.2
280.5
479
327
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
40.7
280.2
356
90
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
49.8
278.5
340
70
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
25.6
277.3
395
159
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
5.8
272.0
822
1497
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
13.0
268.5
491
393
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
35.0
267.3
351
103
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
10.5
261.9
531
525
WX702
NOMESCO Finland
Supraglottic ventilation device
4.0
258.6
1145
3104
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
15.7
258.2
435
287
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.2
256.1
850
1726
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
18.8
255.0
401
220
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
28.4
246.6
341
123
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
43.3
246.5
309
73
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
22.3
245.1
364
168
FM1FN
NOMESCO Finland
Heart function isotope examination
22.0
244.2
364
170
L03AA02
ATC
filgrastim; parenteral
6.0
240.6
701
1216
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
16.4
239.8
396
248
ZXA05
NOMESCO Finland
Left side
2.0
232.1
3907
23051
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
15.0
232.1
398
274
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
29.6
228.1
312
108
WX402
NOMESCO Finland
General anaesthesia
2.3
227.8
2489
12137
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
20.3
227.0
347
175
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
27.1
223.7
313
118
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.8
221.0
793
1747
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.6
219.3
1075
3161
ZXA00
NOMESCO Finland
Right side
1.9
218.6
4091
25005
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
21.9
216.6
323
151
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.7
214.1
650
1184
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
37.0
210.0
272
75
HA1BA
NOMESCO Finland
Extensive X-ray mammography
15.3
209.2
355
238
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
23.8
208.6
303
130
1XC03
NOMESCO Finland
NA
37.6
208.4
269
73
HA1HA
NOMESCO Finland
Tomosynthesis mammography
17.4
205.5
332
196
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
24.0
204.3
296
126
L02AE03
ATC
goserelin; implant
12.2
199.1
374
316
N02BE01
ATC
paracetamol; systemic, rectal
2.3
198.1
11238
99434
L01BC06
ATC
capecitabine; oral
4.4
195.3
756
1794
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
16.9
193.5
316
192
L02AE02
ATC
leuprorelin; implant, parenteral
10.5
192.9
390
382
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
18.0
191.5
305
173
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
15.2
191.1
325
219
A79
ICPC
Malignancy NOS
9.8
187.4
393
412
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.7
186.9
901
2602
N06AX16
ATC
venlafaxine; oral
2.2
185.4
2142
10602
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
184.5
3594
21979
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
34.8
182.0
239
70
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
20.7
180.6
274
135
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.4
178.7
411
505
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
9.5
178.1
380
411
HAC25
NOMESCO Finland
Radical mastectomy
18.7
176.9
278
152
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
25.2
176.5
252
102
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
86.6
174.7
196
23
HAD99
NOMESCO Finland
Other plastic operation on breast
13.9
173.4
306
225
X21
ICPC
Breast sympt/compl female other
5.3
172.5
562
1109
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
12.5
172.1
319
262
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
12.0
171.3
323
275
HAD40
NOMESCO Finland
Mastopexy
16.1
171.1
284
180
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
9.2
169.3
368
411
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
20.7
168.8
256
126
B01AB05
ATC
enoxaparin; parenteral
1.8
165.4
4325
28929
L01CA04
ATC
vinorelbine; systemic
13.3
163.7
294
225
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
16.7
159.6
261
159
HA1SA
NOMESCO Finland
Expansion mammography
17.3
158.5
256
151
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
20.7
158.3
240
118
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
157.5
5400
38970
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
155.5
1396
6054
X19
ICPC
Breast lump/mass female
5.8
154.3
463
828
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
34.6
153.0
201
59
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
25.2
151.5
216
87
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
5.2
146.9
478
940
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
10.3
146.5
298
295
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
22.4
146.2
216
98
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
10.6
143.1
286
274
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
21.5
141.8
212
100
L02BA02
ATC
toremifene; oral
1399.1
140.8
137
*
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
50.3
139.1
169
34
JN4AD
NOMESCO Finland
Body CT examination
2.6
137.9
1081
4333
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
135.5
5132
37522
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
37.3
134.1
173
47
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
3.5
130.9
654
1931
Z3231
NOMESCO Finland
Registered nurse
1.7
129.5
3392
22305
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
9.1
128.3
280
315
M05BA02
ATC
clodronic acid; systemic
24.5
128.2
184
76
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
7.1
127.7
327
473
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
24.9
123.9
177
72
A02BC02
ATC
pantoprazole; systemic
1.6
119.8
8426
70884
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
4.1
117.8
485
1212
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
33.3
117.2
155
47
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
99.4
116.1
128
13
R50.9
ICD-10 Finland
Fever, unspecified
2.0
116.0
1590
8319
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
12.2
113.1
211
176
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
8.0
111.1
262
335
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.9
111.0
324
559
X26
ICPC
Fear of breast cancer female
8.2
110.8
256
317
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
109.5
598
1886
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
9.8
109.5
228
236
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.9
108.5
375
787
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
17.8
108.0
172
98
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.0
107.9
666
2290
Z3226
NOMESCO Finland
Physiotherapist
1.8
107.8
2436
15176
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
17.4
105.9
170
99
XX1AD
NOMESCO Finland
Other CT-examination
11.6
104.8
200
175
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
38.4
103.9
133
35
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
16.9
103.0
167
100
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
7.2
102.9
259
366
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
23.6
101.4
147
63
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
30.1
101.1
137
46
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
50.0
98.0
119
24
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.7
97.0
454
1268
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
47.6
96.4
118
25
ZSZ10
NOMESCO Finland
Secondary repair operation
54.7
95.4
114
21
A46
ICD-10 Finland
Erysipelas
1.9
94.9
1549
8615
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.6
94.6
457
1310
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
94.4
854
3675
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
11.2
93.6
181
163
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
90.7
1389
7536
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
14.5
88.3
152
106
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
87.5
890
4055
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
9.7
87.4
182
189
QBJ00
NOMESCO Finland
Liposuction in trunk
9.1
87.1
189
211
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
23.5
87.1
126
54
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.0
87.0
203
256
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.7
86.9
308
664
3AA13
NOMESCO Finland
NA
21.0
86.0
129
62
J01DB01
ATC
cefalexin; oral
1.5
85.1
9781
87599
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
36.3
83.5
108
30
N62
ICD-10 Finland
Hypertrophy of breast
2.5
82.4
705
2942
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
17.5
80.1
128
74
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
78.4
1603
9579
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
3.8
78.1
349
937
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
57.9
77.9
92
16
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.8
77.4
272
582
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
76.7
619
2501
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
76.6
522
10716
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
14.2
76.1
132
94
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
13.5
73.5
130
97
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
16.6
72.0
117
71
J01MA12
ATC
levofloxacin; systemic
1.6
68.5
2002
13203
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
15.3
68.0
114
75
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.5
67.1
151
180
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
15.8
66.5
110
70
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
64.0
10845
100977
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.9
63.7
274
713
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
58.0
63.6
75
13
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
63.6
649
2953
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.9
63.5
215
443
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
318.5
63.4
64
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
63.3
1073
5999
N02AA05
ATC
oxycodone; systemic
1.7
62.4
1613
10269
Z51.5
ICD-10 Finland
Palliative care
2.2
60.5
647
3006
WF004
NOMESCO Finland
Palliative radiotherapy
4.0
60.2
250
630
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.9
60.0
376
1303
ZXE00
NOMESCO Finland
One hour or less
1.4
59.9
4564
36641
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
45.2
58.5
72
16
HA1DA
NOMESCO Finland
Restricted mammography
16.6
58.0
94
57
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
21.7
56.9
84
39
QBA00
NOMESCO Finland
Puncture of skin of trunk
8.3
56.8
129
157
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
56.8
851
4544
B01AB10
ATC
tinzaparin; parenteral
1.9
56.2
894
4879
SPAT1269
SPAT
Other puncture and/or drainage
6.5
55.9
149
230
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
55.9
696
3454
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.3
55.5
290
885
B29
ICPC
Lymph/immune mech sympt/complt other
8.2
55.4
127
157
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.7
53.3
6858
77379
WX110
NOMESCO Finland
Local anesthesy
1.3
52.9
7777
68805
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
14.4
52.1
89
62
HAD20
NOMESCO Finland
Liposuction of breast
13.5
51.7
91
68
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
6.7
51.1
133
199
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
7.4
51.0
124
168
S18
ICPC
Laceration/cut
1.3
50.3
4734
38990
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
59.2
50.3
59
10
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
49.2
595
2914
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
15.0
48.8
82
55
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
11.3
48.2
92
82
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
48.0
263
832
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
26.5
47.6
66
25
WX704
NOMESCO Finland
Intubation
1.8
46.6
804
4507
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
45.9
1923
13665
HAD00
NOMESCO Finland
Augmentation mammoplasty
16.5
45.8
74
45
9703
FHL
Breast resection
3.5
45.7
223
646
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.5
45.2
219
631
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.8
44.5
304
1113
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
9.5
44.2
92
97
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
11.6
44.1
83
72
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
43.0
2268
16845
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.5
42.2
154
345
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
42.2
502
2441
RD211
NOMESCO Finland
NA
2.0
41.9
532
2659
N64.9
ICD-10 Finland
Disorder of breast, unspecified
3.4
41.1
205
606
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
40.7
695
3879
N61
ICD-10 Finland
Inflammatory disorders of breast
2.8
40.6
277
1015
SPAT1152
SPAT
Removal of foreign body from under the skin
2.4
39.9
353
1496
HAA10
NOMESCO Finland
Biopsy of mammary gland
3.7
39.9
181
496
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.7
39.5
888
5402
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
27.1
39.3
54
20
5BX04
NOMESCO Finland
NA
57.6
39.2
46
8
D24
ICD-10 Finland
Benign neoplasm of breast
2.4
38.9
340
1433
WF002
NOMESCO Finland
Radical radiotherapy
2.4
38.8
336
1406
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
12.6
38.8
70
56
1DB03
NOMESCO Finland
NA
86.3
38.8
43
5
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
9.5
38.4
80
85
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
14.5
38.4
65
45
N05CF01
ATC
zopiclone; oral
1.3
38.3
3862
31767
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.5
38.0
1232
8243
ZZS55
NOMESCO Finland
Distension of tissue expander
46.1
37.8
46
10
3030
Kela drug reimbursment
Abemaciclib
102.8
37.7
41
*
1515
Kela drug reimbursment
NA
102.8
37.7
41
*
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
5.4
37.5
116
218
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
29.5
37.2
50
17
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
37.2
2109
15822
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
37.0
676
3857
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
8.6
36.3
80
94
1XC13
NOMESCO Finland
NA
26.4
36.2
50
19
OAA41
NOMESCO Finland
Health check based on individual needs
11.6
35.8
67
58
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.6
35.2
257
983
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
35.1
326
1416
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
5.6
34.8
103
184
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
34.4
1300
8989
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
4.9
34.3
114
233
XX2ET
NOMESCO Finland
NA
28.8
34.1
46
16
JN5AN
NOMESCO Finland
Total body isotope imaging
26.2
34.0
47
18
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.3
33.4
172
522
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
18.9
33.4
51
27
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
38.3
33.3
42
11
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
5.9
32.9
94
161
HA1AE
SPAT
NA
2.7
32.9
235
888
D05.0
ICD-10 Finland
Lobular carcinoma in situ
7.2
32.7
80
111
XX9TE
NOMESCO Finland
Compementary ultrasound examination
4.4
32.7
120
272
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
14.5
32.6
55
38
8524/3-C50.4
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast
72.3
31.8
36
5
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
31.8
813
5116
1BC02
NOMESCO Finland
NA
43.4
31.8
39
9
L01EF03
ATC
abemaciclib; oral
87.7
31.7
35
*
QCJ00
NOMESCO Finland
Liposuction in upper limb
18.2
31.7
49
27
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
22.0
31.7
46
21
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
6.1
31.5
87
143
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.3
31.4
313
1408
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
12.8
31.0
55
43
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
3.8
30.8
135
361
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
35.5
30.5
39
11
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
6.2
30.2
82
132
JN6AD
NOMESCO Finland
CT of torso and neck
3.3
30.2
159
492
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
11.2
30.1
57
51
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.5
29.8
245
1002
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
106.9
29.6
32
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.2
29.3
159
503
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
26.7
29.2
40
15
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
7.7
29.0
68
89
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
28.9
564
3284
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
7.2
28.8
70
97
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.8
28.7
62
71
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
28.3
770
4919
L95
ICPC
Osteoporosis
1.8
28.1
493
2771
8507/3-C50.4
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast
39.0
28.0
35
9
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.4
27.7
235
978
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.0
27.6
370
1889
Z31.6
ICD-10 Finland
General counselling and advice on procreation
8.6
27.5
60
70
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
53.4
27.1
32
6
8522/3-C50.1
ICD-O-3
Infiltrating duct and lobular carcinoma of central portion of breast
62.1
26.9
31
5
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
26.7
795
5196
WE200
NOMESCO Finland
Profylactive therapy of malignancy with hormones
140.2
26.6
28
*
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
6.3
26.2
70
111
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
26.0
254
1132
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
21.2
26.0
38
18
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
25.9
4552
39583
THA00
NOMESCO Finland
Needle biopsy of mamilla
7.6
25.6
60
79
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.2
25.3
138
440
HAA01
NOMESCO Finland
Suture of mammary gland
25.0
25.2
35
14
WF099
NOMESCO Finland
Other radiotherapy
4.6
25.1
88
192
M05BA06
ATC
ibandronic acid; systemic
2.0
25.1
329
1670
GA5AA
NOMESCO Finland
Rib X-ray examination
5.2
25.0
78
150
SPAT1153
SPAT
Removal of sutures
1.3
25.0
3511
29736
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.6
25.0
476
7475
A21
ICPC
Risk factor for malignancy
8.4
24.9
55
66
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.6
24.6
112
311
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
24.1
591
8808
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
5.3
24.0
73
137
5702
FHL
Local lymph node removal (eg armpit, groin)
4.4
23.9
87
198
QBA10
NOMESCO Finland
Incision of skin of trunk
3.4
23.8
118
351
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
23.6
941
6561
8522/3-C50.2
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast
31.0
23.6
31
10
9706
FHL
Ablation mammae, includes axillary exploration
5.8
23.2
66
114
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.6
23.2
527
7978
N05CB02
ATC
barbiturates in combination with other drugs
1.8
23.1
410
2318
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
23.0
1049
14039
ZSZ00
NOMESCO Finland
Primary repair operation
10.8
23.0
44
41
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
7.7
22.9
53
69
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.5
22.3
107
311
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.3
22.2
209
916
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
3.4
22.1
109
324
B01AC04
ATC
clopidogrel; oral
0.7
22.0
644
9287
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.4
22.0
110
330
C10AA05
ATC
atorvastatin; oral
0.8
22.0
2942
34439
156
Kela drug reimbursment
Lapatinib
17.0
21.7
34
20
5BA08
NOMESCO Finland
NA
4.0
21.7
87
218
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
14.4
21.6
36
25
8480/3-C50.2
ICD-O-3
Mucinous adenocarcinoma of upper-inner quadrant of breast
43.3
21.4
26
6
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
21.2
721
10133
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
13.4
20.9
36
27
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.5
20.8
686
4591
A08
ICPC
Swelling
1.7
20.6
469
2860
A14AB01
ATC
nandrolone; parenteral
6.6
20.6
53
81
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.6
20.6
156
615
1741A
ICD-9 Finland
Malignant neoplasm of female breast, Central portion
9.8
20.5
41
42
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
9.0
20.5
43
48
ULC02
NOMESCO Finland
Hysteroscopy
1.5
20.5
745
5094
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.9
20.5
122
416
J94.8
ICD-10 Finland
Other specified pleural conditions
2.7
20.4
139
514
C10AA01
ATC
simvastatin; oral
0.8
20.4
3561
40691
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
4.2
20.4
78
187
L01XE07
ATC
[U] lapatinib; oral
16.9
20.4
32
19
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
5.3
20.4
62
117
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.5
20.2
156
620
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
20.2
1152
8585
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
6.9
20.1
50
73
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
5.4
20.1
60
111
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
6.9
19.8
49
71
ZXD20
NOMESCO Finland
Day surgery
1.3
19.8
1406
10846
WW200
SPAT
NA
0.7
19.7
513
7560
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
9.8
19.5
39
40
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
19.4
852
11484
M05BA04
ATC
alendronic acid; oral
1.4
19.1
1143
8579
NK6SN
NOMESCO Finland
Bone SPECT
16.7
19.1
30
18
S76
ICPC
Skin infection other
1.6
19.1
469
2922
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
13.9
19.0
32
23
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
3.2
18.9
101
320
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
18.7
4197
37048
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
7.2
18.4
44
61
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
0.6
18.3
294
4800
1CD01
NOMESCO Finland
NA
6.0
18.2
50
84
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.4
18.1
159
678
B04
ICPC
Blood symptom/complaint
4.1
17.9
69
168
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
17.8
365
2164
ZZR00
NOMESCO Finland
Flap of skin
2.0
17.6
219
1094
X79
ICPC
Benign neoplasm breast female
8.8
17.6
37
42
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
17.5
1328
16625
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.1
17.2
95
309
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.6
17.2
496
3216
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
17.2
685
4772
Z2221
NOMESCO Finland
Medical doctor
1.2
17.1
2844
24333
L09
ICPC
Arm symptom/complaint
1.6
17.1
438
2758
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.6
17.0
478
3086
WW500
NOMESCO Finland
Blood transfusion
1.7
16.9
343
2025
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.8
16.8
109
394
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
21.8
16.8
24
11
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.0
16.8
99
337
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
5.1
16.7
52
102
C08CA01
ATC
amlodipine; oral
0.8
16.7
2833
32602
C507
ICD-10 Finland
NA
15.0
16.6
27
18
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
8.8
16.6
35
40
8246/3-C50.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of breast, NOS
90.1
16.5
18
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
16.5
1233
9571
L02AB01
ATC
megestrol; oral (progestogens)
170.1
16.5
17
*
PJ5YQ
NOMESCO Finland
NA
17.9
16.4
25
14
WB321
NOMESCO Finland
Multiple adjuvant therapy of malignancy with biomodifiers
10.7
16.4
31
29
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
4.0
16.4
65
163
NF3AA
NOMESCO Finland
Femur X-ray examination
2.1
16.3
188
909
X62
ICPC
Female Genital, Administrative procedure
40.1
16.3
20
5
AN1
HP
Coronary angiography
0.7
16.3
455
6625
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
16.3
715
5079
N05CF02
ATC
zolpidem; oral
1.2
16.2
1978
16355
1748X
ICD-9 Finland
Malignant neoplasm of female breast, Other specified sites of female breast
6.4
16.2
42
66
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.1
16.1
177
840
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
16.1
692
4898
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
3.2
16.1
84
264
XX2VW
NOMESCO Finland
Radiologic consultation
3.4
16.0
77
227
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
16.0
1906
15718
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
10.0
15.9
31
31
Z2446
NOMESCO Finland
Social worker
1.5
15.6
534
3604
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
9.7
15.6
31
32
M54.4
ICD-10 Finland
Lumbago with sciatica
0.8
15.5
1149
14443
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
13.7
15.4
26
19
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.7
15.4
300
1752
E0000UV
ATC
NA
1.2
15.3
4256
38096
SPAT1211
SPAT
Application of soft bandage
1.4
15.2
869
6470
L04AX01
ATC
azathioprine; systemic
0.5
15.2
141
2650
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
14.9
1787
21302
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
14.8
1102
13846
8522/3-C50.8
ICD-O-3
Infiltrating duct and lobular carcinoma of overlapping lesion of breast
56.7
14.8
17
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
5.1
14.6
45
88
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
14.6
350
2169
XX9XW
NOMESCO Finland
NA
3.3
14.6
72
218
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
14.5
163
780
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.8
14.5
877
11314
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.3
14.4
131
569
SPAT1324
SPAT
Screening procedure
0.8
14.4
1551
18687
C10AA07
ATC
rosuvastatin; oral
0.8
14.3
1880
22207
G03AC03
ATC
levonorgestrel; systemic
1.2
14.1
1677
13811
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
11.9
14.0
25
21
L58.9
ICD-10 Finland
Radiodermatitis, unspecified
15.7
13.9
22
14
A04AA03
ATC
tropisetron; systemic
3.7
13.8
59
159
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
4.3
13.8
50
116
ZX100
NOMESCO Finland
Oral
2.3
13.8
124
537
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
2.9
13.8
83
289
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
2.3
13.8
124
538
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
0.6
13.6
185
3142
P01BA02
ATC
hydroxychloroquine; oral
0.7
13.6
600
8096
C50.62
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, lobular tumor
75.1
13.6
15
*
TPX15
NOMESCO Finland
Removal of vascular injection port
3.6
13.5
59
163
1514
Kela drug reimbursment
NA
140.0
13.4
14
*
3002
Kela drug reimbursment
Ribociclib
140.0
13.4
14
*
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
16.2
13.4
21
13
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
13.4
179
923
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
7.0
13.3
32
46
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
4.1
13.2
50
122
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
13.1
2750
23958
WE100
NOMESCO Finland
Profylactic cytostatic therapy
11.5
12.8
23
20
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
11.5
12.8
23
20
9702
FHL
Breast exploration and possible tumor removal
1.8
12.7
221
1251
N81.1
ICD-10 Finland
Cystocele
0.7
12.7
629
8344
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.5
12.7
77
1645
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
17.3
12.5
19
11
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
12.5
228
1311
8524/3-C50.2
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast
130.0
12.4
13
*
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
4.6
12.4
42
92
HAB30
NOMESCO Finland
Excision of mamilla or areola
7.6
12.3
28
37
N64.8
ICD-10 Finland
Other specified disorders of breast
2.9
12.3
74
259
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
10.5
12.2
23
22
8480/3-C50.1
ICD-O-3
Mucinous adenocarcinoma of central portion of breast
37.5
12.2
15
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.7
12.1
80
295
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
0.5
12.1
70
1522
HAA00
NOMESCO Finland
Incision of mammary gland
6.0
12.0
32
53
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
8.1
12.0
26
32
C01DA14
ATC
isosorbide mononitrate; oral
0.8
12.0
693
8996
9719
FHL
Other measure in this category
4.0
11.9
46
115
205
Kela drug reimbursment
Chronic hypertension
0.8
11.9
2000
23148
8523/3-C50.2
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-inner quadrant of breast
46.6
11.9
14
*
TQX05
NOMESCO Finland
Skin puncture, unspecified location
4.9
11.8
37
75
A10AA02
ATC
NA
0.5
11.7
70
1506
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
5.4
11.7
34
63
N64.5
ICD-10 Finland
Other signs and symptoms in breast
1.7
11.7
254
1538
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.3
11.7
703
5281
8507/3-C50.5
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-outer quadrant of breast
64.9
11.6
13
*
WB213
NOMESCO Finland
Adjuvant hormone therapy of malignancy
64.9
11.6
13
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
3.8
11.6
47
123
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
11.5
259
3925
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
0.7
11.4
264
3984
N81.6
ICD-10 Finland
Rectocele
0.8
11.4
624
8168
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
6.7
11.4
28
42
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
3.3
11.3
54
162
L71
ICPC
Malignant neoplasm musculoskeletal
10.5
11.2
21
20
G47.3
ICD-10 Finland
Sleep apnoea
0.8
11.2
1146
13910
ZX121
NOMESCO Finland
Central venous catheter
3.6
11.2
48
132
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
11.1
1699
19850
8480/3-C50.5
ICD-O-3
Mucinous adenocarcinoma of lower-outer quadrant of breast
25.0
11.1
15
6
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.7
11.1
424
5850
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies                        
12.7
11.1
19
15
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
11.1
1068
8568
1AA01
NOMESCO Finland
NA
7.6
11.1
25
33
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.2
11.1
109
498
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
3.1
11.0
59
192
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.5
11.0
74
1527
C10AX09
ATC
ezetimibe; oral
0.7
11.0
582
7652
L03.3
ICD-10 Finland
Cellulitis of trunk
2.7
11.0
74
278
XX9CN
NOMESCO Finland
NA
13.9
10.9
18
13
ZX050
NOMESCO Finland
Stereotactic radiotherapy
3.1
10.9
58
188
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.6
10.9
277
1748
A41.9
ICD-10 Finland
Sepsis, unspecified
1.6
10.8
242
1480
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.2
10.8
1368
11330
TLC02
NOMESCO Finland
Simple extraction of IUD
1.5
10.8
390
2671
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.6
10.7
168
2752
8211/3-C50.4
ICD-O-3
Tubular adenocarcinoma of upper-outer quadrant of breast
10.5
10.7
20
19
WE198
NOMESCO Finland
Palliative cystotatic therapy
8.8
10.7
22
25
N06AX11
ATC
mirtazapine; oral
1.2
10.7
3395
30497
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.5
10.7
313
2046
HA1DT
NOMESCO Finland
Mammary gland biopsy with MRI guidance
21.4
10.7
15
7
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
2.9
10.7
63
219
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
1.7
10.7
213
1261
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
12.9
10.6
18
14
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.3
10.5
865
6803
ZXF20
NOMESCO Finland
Interruption caused by problems of surgical technique
6.5
10.4
26
40
A07EC01
ATC
sulfasalazine; oral, rectal
0.7
10.4
461
6216
1XC0V
NOMESCO Finland
NA
110.0
10.4
11
*
ZXA10
NOMESCO Finland
Bilateral
1.2
10.4
1942
16703
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
5.2
10.4
31
60
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.5
10.3
304
1991
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.7
10.3
190
1097
H02AB04
ATC
methylprednisolone; systemic
0.8
10.3
1117
13483
PJW20
NOMESCO Finland
Lymphovenous shunt
18.8
10.2
15
8
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
0.7
10.2
374
5189
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
0.6
10.2
177
2829
M48.0
ICD-10 Finland
Spinal stenosis
0.8
10.2
810
10109
RF210
NOMESCO Finland
NA
1.6
10.1
258
1633
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
3.7
10.1
42
113
J01FF01
ATC
clindamycin; systemic
1.2
10.1
2638
23341
M53.1
ICD-10 Finland
Cervicobrachial syndrome
0.8
10.0
704
8914
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
14.5
10.0
16
11
L04AA13
ATC
leflunomide; oral
0.6
10.0
117
2053
I25.2
ICD-10 Finland
Old myocardial infarction
0.6
9.9
121
2108
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
4.7
9.9
32
68
N39.3
ICD-10 Finland
Stress incontinence
0.8
9.9
666
8478
8097/3-C44.3
ICD-O-3
Basal cell carcinoma, nodular of skin of other and unspecified parts of face
7.6
9.9
22
29
R10.1
ICD-10 Finland
Pain localized to upper abdomen
0.8
9.8
1230
14642
A06AH03
ATC
naloxegol; oral
2.2
9.8
92
412
8523/3-C50.5
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast
26.0
9.8
13
5
1740A
ICD-9 Finland
Malignant neoplasm of female breast, Nipple and areola
8.1
9.8
21
26
R06AE07
ATC
cetirizine; oral
1.1
9.7
4908
45420
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
0.7
9.6
395
5387
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.0
9.6
126
648
8523/3-C50.8
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast
55.0
9.6
11
*
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
55.0
9.6
11
*
A10AA01
ATC
NA
0.4
9.6
50
1121
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
5.0
9.5
29
58
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
3.0
9.5
51
168
OAB39
NOMESCO Finland
Sexual health guidance
17.5
9.4
14
8
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
7.5
9.4
21
28
8523/3-C50.3
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-inner quadrant of breast
+∞
9.4
9
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.8
9.3
1667
19239
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
9.3
1401
16410
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.9
9.3
1895
21645
R60.0
ICD-10 Finland
Localized oedema
1.2
9.2
1063
8710
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
2.5
9.2
67
265
9710
FHL
Existence of a relapse
13.6
9.2
15
11
335
Kela drug reimbursment
Lapatinib
13.6
9.2
15
11
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.6
9.1
233
1479
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.3
9.1
780
6168
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.1
9.0
3389
30735
1XC14
NOMESCO Finland
NA
15.6
9.0
14
9
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.3
9.0
78
337
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.7
9.0
393
5303
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
9.0
1187
14065
N05BA04
ATC
oxazepam; oral
1.2
8.9
2614
23297
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
0.2
8.9
6
378
HAC99
NOMESCO Finland
Other mastectomy
18.6
8.9
13
7
L88
ICPC
Rheumatoid/seropositive arthritis
0.7
8.9
206
3101
I20.09
ICD-10 Finland
Unstable angina
0.6
8.9
181
2793
KMAK
NOMESCO Finland
NA
0.9
8.9
4590
49317
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
0.7
8.9
283
4020
TJA10
NOMESCO Finland
Laparocentesis
3.5
8.9
39
111
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
5.7
8.9
24
42
N03AG01
ATC
valproic acid; systemic, rectal
0.7
8.8
247
3589
J05AB11
ATC
valaciclovir; oral
1.2
8.8
1338
11277
C10AA04
ATC
fluvastatin; oral
0.8
8.8
495
6451
G43
ICD-10 Finland
Migraine
0.6
8.8
128
2129
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
0.7
8.8
216
3213
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.5
8.8
314
2153
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.1
8.7
5203
48538
N02AJ06
ATC
codeine and paracetamol; systemic
1.1
8.7
3646
33286
E66.8
ICD-10 Finland
Other obesity
0.7
8.7
236
3446
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.4
8.7
36
877
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
3.9
8.7
34
88
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
14.0
8.7
14
10
8523/3-C50.1
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of central portion of breast
50.0
8.7
10
*
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.7
8.6
428
5676
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.6
8.6
193
1184
HA3RT
NOMESCO Finland
Coagulation of mammary neoplasm under radiological guidance
7.6
8.6
19
25
OAB47
SPAT
NA
0.5
8.6
65
1290
I10
ICD-10 Finland
Essential (primary) hypertension
0.9
8.6
5648
59904
B01AB04
ATC
dalteparin; parenteral
1.4
8.6
439
3216
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
8.6
100
1754
OAB42
SPAT
NA
0.6
8.5
166
2586
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
11.5
8.5
15
13
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.7
8.5
182
1103
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
2.9
8.5
50
175
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
0.7
8.4
431
5689
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour                  
7.3
8.4
19
26
HAF10
NOMESCO Finland
Repair after excision of local recurrence of breast cancer using graft or flap
90.0
8.4
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
0.9
8.4
2442
27202
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
3.8
8.4
33
86
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.9
8.4
1785
20330
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
3.7
8.4
34
91
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.4
8.3
68
287
HA1S1
NOMESCO Finland
Photography of breasts
4.4
8.3
28
63
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
5.0
8.3
25
50
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.7
8.3
148
851
N05BA06
ATC
lorazepam; systemic, sublingual
1.4
8.3
433
3188
RF190
NOMESCO Finland
NA
9.4
8.3
16
17
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
0.9
8.2
3057
33535
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.4
8.2
37
875
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.7
8.2
273
3846
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
1.9
8.2
115
612
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
4.4
8.2
28
64
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.9
8.2
1609
18440
L04AA06
ATC
mycophenolic acid; systemic
0.4
8.2
29
752
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
3.2
8.1
40
125
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.2
8.1
1258
10626
N02AA01
ATC
morphine; systemic, rectal
2.2
8.1
78
358
8507/3-C50.1
ICD-O-3
Invasive micropapillary carcinoma of breast of central portion of breast
33.3
8.1
10
*
HAF99
NOMESCO Finland
Other operation for local recurrence of breast cancer
33.3
8.1
10
*
8503/3-C50.9
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of breast, NOS
22.0
8.0
11
5
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
0.8
8.0
505
6482
L04AB01
ATC
etanercept; parenteral
0.4
7.9
32
787
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
2.4
7.9
65
274
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
3.4
7.9
36
106
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
0.7
7.9
207
3040
WX725
NOMESCO Finland
Noninvasive ventilation
1.4
7.9
362
2606
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
7.9
52
197
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
0.6
7.9
84
1509
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.2
7.8
876
7155
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.8
7.8
135
771
M54.2
ICD-10 Finland
Cervicalgia
0.7
7.7
386
5113
E66.01
ICD-10 Finland
Obesity due to excess calories
0.8
7.7
408
5357
C09AA05
ATC
ramipril; oral
0.9
7.7
1644
18729
E66.00
ICD-10 Finland
Metabolic syndrome
0.7
7.7
220
3176
J02AC01
ATC
fluconazole; systemic
1.1
7.6
5217
48915
OAB44
SPAT
NA
0.6
7.6
108
1803
R51.80
ICD-10 Finland
Headache
0.8
7.6
986
11707
R5110
SPAT
NA
1.5
7.6
236
1573
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.4
7.6
393
2891
XX3XT
NOMESCO Finland
Other labeling with other radiological guidance
25.0
7.6
10
*
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
25.0
7.6
10
*
C50.0
ICD-10 Finland
Malignant neoplasm: Nipple and areola
6.7
7.6
18
27
HAD35
NOMESCO Finland
Reduction mammoplasty with transplantation of areola
4.2
7.6
27
65
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
4.9
7.5
23
47
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
2.5
7.5
56
225
R31
NOMESCO Finland
Adaptation training
4.5
7.5
25
56
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.9
7.5
4285
45919
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
0.4
7.5
33
783
WX707
NOMESCO Finland
Fiberoscopic intubation
3.3
7.5
35
106
P20
ICPC
Memory disturbance
0.8
7.5
750
9133
R03AC02
ATC
salbutamol; inhalant
0.9
7.5
5144
54589
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.1
7.4
38
123
HAD41
NOMESCO Finland
Transposition of areola
80.1
7.4
8
*
A55
ICPC
General and Unspecified, Local injection/infiltration
2.2
7.4
70
319
ZXC82
NOMESCO Finland
Microsurgical
5.9
7.3
19
32
K30
ICD-10 Finland
Functional dyspepsia
0.8
7.3
758
9199
158
Kela drug reimbursment
Everolimus
5.6
7.3
20
36
A10BA02
ATC
metformin; oral
0.9
7.3
1881
21158
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
0.5
7.3
55
1091
L01EF02
ATC
ribociclib; oral
+∞
7.3
7
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.7
7.3
261
3627
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.8
7.2
777
9393
318
Kela drug reimbursment
Teriparatide
0.2
7.2
8
368
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
0.8
7.2
623
7698
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
0.6
7.2
146
2248
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
1.9
7.1
94
491
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
3.5
7.1
31
89
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
2.9
7.1
41
141
N85.9
ICD-10 Finland
Noninflammatory disorder of uterus, unspecified
2.0
7.1
87
440
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
0.7
7.1
165
2477
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
7.9
7.1
15
19
ZX002
NOMESCO Finland
Simple dose design for radiotherapy based on tomography - isocentric therapy
7.9
7.1
15
19
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
6.0
7.0
18
30
AN4
HP
Balloon angioplasty and drug eluding stent
0.5
7.0
59
1130
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
0.8
7.0
384
5020
A02BC05
ATC
esomeprazole; systemic
1.1
7.0
4560
42580
X18
ICPC
Breast pain female
1.7
6.9
146
887
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.0
6.9
86
441
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
1.8
6.9
110
615
G44.2
ICD-10 Finland
Tension-type headache
0.8
6.9
1010
11865
L03
ICPC
Low back symptom/complaint
0.9
6.9
2049
22830
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.1
6.9
2353
21158
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
0.7
6.9
333
4422
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
4.0
6.8
25
62
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.9
6.8
1449
16522
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.6
6.8
129
2016
ZZS50
NOMESCO Finland
Insertion of tissue expander
9.3
6.8
13
14
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
2.5
6.8
48
190
8522/3-C50.3
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-inner quadrant of breast
39.9
6.7
8
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.3
6.7
427
3246
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
0.6
6.7
120
1899
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
0.7
6.7
163
2419
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.5
6.7
62
1150
00044
NOMESCO Finland
NA
22.5
6.7
9
*
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.3
6.7
458
3522
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
1.6
6.6
140
852
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
0.7
6.6
261
3569
SGA01
NOMESCO Finland
Tooth opening as first aid
0.8
6.6
871
10328
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
0.7
6.6
317
4213
L01XE10
ATC
[U] everolimus; oral
7.8
6.6
14
18
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.0
6.6
77
387
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
1.6
6.6
159
1003
RF410
NOMESCO Finland
NA
1.8
6.6
105
588
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.7
6.5
207
2932
ZYC01
NOMESCO Finland
Remote contact by phone
1.4
6.5
332
2442
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.1
6.5
32
102
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.2
6.5
1141
9751
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.1
6.5
2230
20051
M35.3
ICD-10 Finland
Polymyalgia rheumatica
0.7
6.4
202
2865
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.5
6.4
47
939
ZYC01
SPAT
NA
0.7
6.4
215
3021
L02BG01
ATC
aminoglutethimide; oral
69.8
6.4
7
*
I20.99
ICD-10 Finland
Angina pectoris, unspecified
0.7
6.4
259
3532
N03AF01
ATC
carbamazepine; oral, rectal
0.7
6.4
252
3452
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
0.8
6.4
533
6615
SPAT1059
SPAT
Spirometry at the office
0.7
6.4
263
3577
S50
ICPC
Skin, Medication/prescr/renewal
2.2
6.4
61
282
A87
ICPC
Complication of medical treatment
2.1
6.4
70
341
I20.90
ICD-10 Finland
Angina pectoris, unspecified
0.6
6.4
112
1773
C08CA13
ATC
lercanidipine; oral
0.8
6.4
959
11237
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.0
6.4
75
378
A26
ICPC
Fear of cancer, NOS
2.2
6.4
56
250
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
0.8
6.3
390
5018
M77.1
ICD-10 Finland
Lateral epicondylitis
0.8
6.3
360
4680
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.4
6.3
49
204
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.2
6.3
58
263
ZZR70
NOMESCO Finland
Perforator flaps
8.1
6.3
13
16
N05AX08
ATC
risperidone; systemic
0.8
6.3
342
4472
K08.80
ICD-10 Finland
Toothache NOS
0.8
6.3
440
5569
NK6BT
NOMESCO Finland
Bone biopsy with X-ray guidance
9.2
6.3
12
13
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
0.5
6.3
48
945
M03BC01
ATC
orphenadrine (citrate); systemic
0.9
6.3
1865
20790
T89
ICPC
Diabetes insulin dependent
0.6
6.3
95
1557
8503/3-C50.4
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast
18.0
6.3
9
5
GAC10
NOMESCO Finland
Removal of foreign body from pleural cavity
18.0
6.3
9
5
M907, C5041
ICD-10 Finland
NA
+∞
6.2
6
*
8507/3-C50.8
ICD-O-3
Invasive micropapillary carcinoma of breast of overlapping lesion of breast
+∞
6.2
6
*
3AF02
NOMESCO Finland
NA
+∞
6.2
6
*
8507/3-C50.3
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-inner quadrant of breast
+∞
6.2
6
*
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.8
6.2
353
4587
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
26.7
6.2
8
*
LCA10
NOMESCO Finland
Curettage of body of uterus
1.4
6.2
306
2236
M54.5
ICD-10 Finland
Low back pain
0.9
6.2
2837
30839
WGA10
NOMESCO Finland
Measurement of pain intensity
7.0
6.2
14
20
N99.3
ICD-10 Finland
Prolapse of vaginal vault after hysterectomy
0.6
6.2
120
1860
H05AA02
ATC
teriparatide; parenteral
0.2
6.2
8
333
C08CA05
ATC
nifedipine; systemic
0.7
6.2
301
3991
GA1CG
NOMESCO Finland
Extensive MRI of chest
4.1
6.2
22
54
HAC30
NOMESCO Finland
Excision of supernumerary mammary gland or mamilla
5.0
6.2
18
36
A10AE04
ATC
insulin glargine; parenteral
0.8
6.2
399
5099
TGA30
NOMESCO Finland
Thoracocentesis
2.5
6.1
45
183
N06AA09
ATC
amitriptyline; systemic
0.8
6.1
834
9860
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.2
6.1
5
279
Z72.8
ICD-10 Finland
Other problems related to lifestyle
3.0
6.1
32
107
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.6
6.1
108
1708
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
0.8
6.1
934
10929
A03FA02
ATC
cisapride; oral, rectal
0.8
6.1
549
6749
WZA10
NOMESCO Finland
Long statement of health and health related matters
1.7
6.0
111
648
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.2
6.0
1173
10111
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
1.7
6.0
118
703

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015377) Calcium [Moles/volume] in Serum or Plasma
8470
46414
2.87
307.65
6.7
2.9
mmol/l
2.4
2.4
48.64
7836
39608
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
8623
57628
2.14
307.65
3.6
3.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
3569
1602
28.64
307.65
4.3
2.3
u/ml
42.3
29.8
2.93
3454
1539
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1320
3316
4.21
307.65
1.2
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
13712
99961
5.87
307.65
12.3
7.0
u/l
78.4
78.6
0.24
13499
93071
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
866
1170
7.69
307.65
1.4
1.3
nmol/l
0.2
0.3
3.46
532
811
(1617658) Protocol used for examination of sentinel lymph nodes
1839
575
35.87
307.65
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
6365
32002
2.69
307.65
9.5
6.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
3422
2885
14.92
307.65
1.4
1.3
—
—
—
0
0
(4035726)
4888
10510
6.36
307.65
1.4
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
8616
55815
2.25
307.65
2.4
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
4288
16089
3.29
307.65
1.3
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
842
521
16.84
307.65
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
6533
39050
2.16
307.65
2.0
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
11389
72510
3.39
307.65
13.0
8.8
e9/l
3.5
4.0
155.45
10574
62684
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
4054
13442
3.72
307.65
4.1
3.7
ug/l
13.9
24.3
1.91
3135
10671
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
2070
1018
23.15
307.65
4.8
2.2
u/ml
56.4
40.2
1.96
2055
998
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
11544
66008
4.31
307.65
9.9
5.4
umol/l
9.2
10.4
42.66
11319
61959
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
9214
67600
1.91
298.56
6.8
6.0
mmol/l
1.2
1.2
34.12
7569
56856
(40768795) Lymph node Pathology biopsy report
613
1189
5.26
292.34
1.1
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
482
779
6.27
278.79
1.2
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
8464
61229
1.85
277.25
5.5
5.3
mmol/l
1.2
1.2
51.70
7923
54733
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
2167
10741
2.16
210.80
2.9
3.7
u/ml
48.5
61.1
1.44
2098
10355
(3023368) Bacteria identified in Blood by Culture
4654
30384
1.74
194.64
3.9
4.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
4512
29836
1.71
176.47
2.0
2.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
5790
41098
1.64
171.01
4.6
3.8
ph
7.4
7.4
9.83
1471
7168
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2181
11701
1.98
168.22
1.7
2.1
g/l
0.2
0.2
30.09
2098
10853
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
7640
60503
1.51
124.76
2.2
2.3
nmol/l
82.4
1606.7
0.50
7077
53723
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1925
10953
1.84
121.08
4.4
3.4
mmol/l
1.2
1.2
6.82
1801
9335
(3024561) Albumin [Mass/volume] in Serum or Plasma
7228
57041
1.49
116.96
3.8
4.4
g/l
35.7
35.6
1.02
6753
52511
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
13267
120292
1.85
109.78
17.8
12.8
ml/min/173m2
80.3
78.0
46.24
12049
98143
(3023323) Follitropin [Units/volume] in Serum or Plasma
1147
5669
2.08
108.56
1.5
1.3
iu/l
41.2
38.9
1.50
1000
4978
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
623
2384
2.65
106.57
1.2
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
527
1863
2.86
105.01
1.4
1.3
u/l
43.0
40.5
0.76
498
1453
(40758358) Immune stain study
82
42
19.35
104.39
1.0
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
13598
125840
1.82
82.64
16.9
13.9
mg/l
21.2
21.4
0.29
11290
98881
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
437
1591
2.76
82.29
1.2
1.2
u/l
59.8
58.9
0.15
275
1070
(3042936) Bacteria identified in Isolate by Culture
2440
16387
1.56
79.22
1.8
1.9
—
—
—
0
0
(3019225) pH of Specimen
2080
13836
1.56
69.60
4.7
4.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
3938
29817
1.41
68.31
1.3
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
204
550
3.69
63.53
1.4
1.7
ug/l
1.5
7.4
1.98
103
321
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
3500
26335
1.41
61.80
3.0
2.9
mmol/l
2.5
2.5
10.23
3151
22932
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
235
737
3.18
57.82
1.2
1.1
u/l
73.9
84.0
1.25
211
571
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
235
740
3.17
57.43
1.2
1.1
u/l
18.0
24.7
1.26
209
556
(3019550) Sodium [Moles/volume] in Serum or Plasma
13951
131813
1.77
55.20
16.9
15.8
mmol/l
139.8
139.8
0.13
13732
128387
(3033658) Prothrombin time (PT) actual/Normal
4091
32125
1.35
54.14
3.3
3.6
%
95.4
94.8
0.76
3991
31238
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
14144
134431
1.86
51.31
15.9
10.6
u/l
24.4
23.8
2.65
13938
129126
(3023103) Potassium [Moles/volume] in Serum or Plasma
13955
132128
1.74
51.09
17.1
16.0
mmol/l
3.9
3.9
4.30
13716
128459
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1827
12624
1.49
49.81
3.4
3.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
255
932
2.73
47.73
1.6
1.5
u/l
5.5
6.1
0.21
126
442
(3044889) 12 lead EKG panel
10051
91160
1.27
38.24
3.7
3.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2524
19262
1.35
38.12
1.7
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
296
1314
2.25
36.53
1.2
1.6
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
59
94
6.21
34.71
1.5
1.2
nmol/l
0.2
0.4
0.84
36
57
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
226
917
2.45
34.28
1.2
1.2
u/l
15.2
22.9
1.60
201
775
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
228
934
2.43
33.88
1.2
1.2
u/l
69.5
83.8
1.75
209
814
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
12620
129312
0.74
33.15
4.8
5.2
mmol/l
2.9
2.9
0.22
11337
118334
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
11725
121324
0.77
32.83
3.8
4.1
mmol/l
1.3
1.3
1.96
10420
109909
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4799
40585
1.25
31.76
4.1
3.1
u/l
36.2
32.4
1.36
4573
38325
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
12228
125728
0.76
31.47
4.3
4.6
mmol/l
1.6
1.6
2.61
10995
114952
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
12342
126711
0.76
31.06
4.3
4.6
mmol/l
4.9
4.9
1.48
11157
116445
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
11528
119165
0.79
28.62
5.4
5.8
mmol/mol
39.5
39.6
0.17
10441
109408
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
3545
29379
1.25
27.22
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
11110
103499
1.23
25.56
22.4
16.9
%
13.8
13.8
3.29
11004
101205
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
433
2490
1.74
25.27
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
433
2490
1.74
25.27
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2066
25218
0.78
23.93
1.2
1.3
u/ml
9.8
13.8
2.00
769
9513
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2172
26317
0.78
23.65
1.3
1.3
iu/ml
33.6
39.3
0.93
688
8629
(3013512) EKG study
4484
38541
1.21
23.53
3.9
3.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
3431
39438
0.81
23.13
3.5
3.8
mg/mmol
6.0
7.3
0.72
1775
22090
(3052851) Hemolysis interference index of Serum or Plasma
608
3901
1.56
23.01
2.6
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
5024
43723
1.20
22.96
4.7
6.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
741
4980
1.49
22.59
1.8
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
12332
125869
0.79
22.10
4.5
4.8
mmol/l
5.9
5.9
0.34
11035
114515
(3051651) Icteric interference index of Serum or Plasma
163
703
2.30
21.74
2.3
3.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1552
19421
0.76
21.54
1.3
1.4
titre
541.6
586.5
0.46
344
4481
(3032080) INR in Blood by Coagulation assay
5622
49632
1.19
21.47
7.3
7.8
inr
1.2
1.2
1.04
1709
13945
(3021589) Normoblasts [#/volume] in Blood
6311
56330
1.18
21.06
10.9
9.3
e9/l
0.0
0.0
1.88
5198
45972
(40768806) Pleura Pathology biopsy report
202
963
2.08
21.02
1.5
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
3278
37542
0.82
20.78
2.8
3.1
mg/l
456.4
510.4
0.22
1706
20866
(3019150) Specific gravity of Urine by Refractometry
2399
28373
0.80
20.77
4.0
4.7
kg/l
1.0
1.0
1.17
383
4391
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
515
3260
1.58
20.70
1.5
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
8021
73153
1.18
20.33
3.7
4.2
mmol/l
6.5
6.6
4.46
7641
68397
(3004809) Band form neutrophils/100 leukocytes in Blood
330
1901
1.73
19.23
2.0
3.4
%
2.5
1.3
5.53
250
1491
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
670
4572
1.47
18.93
1.7
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
3427
38769
0.83
18.59
2.8
3.0
mmol/l
6.3
6.3
0.07
2750
32223
(3003434) Protein [Mass/volume] in Pleural fluid
237
1255
1.88
18.31
1.4
1.4
g/l
35.8
32.7
3.99
219
1138
(3026493) Urate [Moles/volume] in Serum or Plasma
2800
32214
0.82
18.10
2.1
2.4
umol/l
5197.1
4644.0
0.27
2347
27417
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3611
40584
0.84
18.09
1.9
2.1
u/l
167.8
162.5
0.13
3330
37741
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
421
2642
1.59
17.61
1.4
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
6737
61115
1.16
16.83
5.0
6.2
%
27.1
28.7
24.99
6258
56471
(3007853) Bacteria identified in Skin by Aerobe culture
1778
14309
1.26
16.76
1.6
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
403
2539
1.58
16.60
1.4
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
323
1933
1.66
16.40
1.4
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
13546
130344
1.29
16.18
16.0
13.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
6593
59822
1.16
16.17
5.1
6.4
%
8.6
8.4
5.80
6170
55608
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5031
54592
0.86
15.62
2.5
2.8
ug/l
142.7
108.2
9.56
4593
50128
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1650
13271
1.25
15.58
1.6
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1351
16558
0.78
15.48
1.9
2.0
ug/g
121.2
125.7
0.18
1011
12702
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1646
13272
1.25
15.18
1.7
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
118
523
2.23
14.92
1.9
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
10488
107827
0.86
14.83
4.4
4.6
pmol/l
14.9
14.9
0.26
9397
98316
(3006504) Eosinophils/100 leukocytes in Blood
6540
59536
1.15
14.82
4.9
6.1
%
2.7
2.8
4.67
6083
55058
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
370
5504
0.65
14.33
1.5
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
436
6274
0.68
14.29
1.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
293
4565
0.63
14.05
1.2
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
12088
122719
0.84
13.74
5.3
5.6
mu/l
2.1
2.1
0.12
10928
112618
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
240
3874
0.60
13.39
1.6
1.6
iu/ml
0.1
9.1
1.04
60
837
(3012441) Differential panel - Pleural fluid
176
942
1.85
13.29
1.4
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
42
115
3.61
13.09
1.4
3.0
mg/l
1.2
1.3
0.08
22
84
(3008898) HLA-B27 [Presence]
260
4081
0.62
12.90
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
4527
48974
0.87
12.58
4.0
4.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
751
9671
0.75
12.53
2.6
2.9
g/l
10.3
10.3
0.02
678
8837
(3022096) Basophils/100 leukocytes in Blood
6322
57838
1.14
12.48
4.9
6.2
%
0.7
0.7
0.75
5883
53477
(3013139) Helicobacter pylori Ag [Presence] in Stool
814
10355
0.76
12.42
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
197
1118
1.75
12.29
1.3
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
873
10975
0.77
12.17
3.1
3.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
6569
60329
1.13
12.04
4.8
6.0
%
57.1
56.7
1.79
6122
55947
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
208
1208
1.71
11.96
1.3
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
6078
64366
0.88
11.93
3.6
4.1
estimate
0.0
0.0
0.69
1215
11401
(3023199) Leukocytes [#/volume] in Pleural fluid
200
1151
1.72
11.89
1.4
1.4
e6/l
4520.8
3036.7
0.20
148
827
(3015171) Extractable nuclear Ab [Units/volume] in Serum
448
6199
0.70
11.87
1.2
1.3
u/ml
1.2
1.0
0.07
38
587
(3021601) Nitrite [Presence] in Urine by Test strip
6159
64954
0.89
10.87
5.0
5.5
estimate
0.0
0.0
3.28
1216
11461
(3028308) Erythrocytes [#/volume] in Pleural fluid
180
1040
1.72
10.61
1.4
1.4
e6/l
32568.1
46571.5
0.52
103
582
(46235355) HIV 1 and 2 tests - Meaningful Use set
1110
13344
0.81
10.53
1.4
1.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
150
825
1.80
10.49
1.3
1.3
u/l
444.1
360.4
0.28
142
780
(3011397) Hemoglobin [Presence] in Urine by Test strip
2890
31937
0.87
10.48
3.3
4.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
14230
138499
1.35
10.46
27.5
20.7
e9/l
258.6
263.0
14.68
14039
134516
(3009261) Glucose [Presence] in Urine by Test strip
6235
65600
0.89
10.36
3.7
4.1
estimate
0.0
0.0
0.05
1227
11551
(3017181) Myelocytes/100 leukocytes in Blood
1319
10817
1.22
10.27
2.8
4.2
%
1.9
0.9
15.38
516
2766
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
234
1460
1.59
10.23
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
232
1450
1.59
10.08
2.6
3.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2858
31527
0.87
10.04
2.2
2.3
mg/l
3.0
3.0
0.44
2424
26884
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1380
11408
1.21
9.91
2.4
3.3
ng/l
72.0
82.6
7.58
1187
9619
(3035941) MCH [Entitic mass]
14230
138559
1.34
9.89
27.3
20.6
pg
30.4
30.2
39.74
14136
136352
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
121
635
1.89
9.85
1.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
121
635
1.89
9.85
1.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
121
635
1.89
9.85
1.3
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
14230
138568
1.33
9.80
27.4
20.6
fl
92.0
91.2
83.36
14136
136365
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
121
637
1.88
9.76
1.3
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1028
12355
0.81
9.72
1.4
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2374
20596
1.16
9.71
2.9
3.0
mmol/l
0.8
0.8
0.08
2198
18991
(3010813) Leukocytes [#/volume] in Blood
14231
138591
1.33
9.69
27.5
20.7
e9/l
6.2
6.5
12.18
14023
134160
(3026361) Erythrocytes [#/volume] in Blood
14230
138580
1.33
9.69
27.5
20.7
e12/l
4.3
4.4
125.40
14024
134128
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
174
1027
1.68
9.53
1.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
174
1027
1.68
9.53
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
174
1027
1.68
9.53
1.3
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2742
30238
0.87
9.51
1.2
1.3
u/ml
1.4
1.5
0.21
624
7940
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1262
10386
1.22
9.48
3.7
2.6
ml/min/173m2
67.6
63.6
4.08
520
4189
(3000963) Hemoglobin [Mass/volume] in Blood
14230
138605
1.33
9.46
27.6
20.8
g/l
129.8
132.0
94.00
14139
136444
(3005322) IgE [Units/volume] in Serum or Plasma
670
8431
0.77
9.40
1.2
1.3
u/ml
192.1
176.6
0.24
607
7763
(3017143) Hepatitis C virus Ab [Presence] in Serum
924
11177
0.80
9.27
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2227
19291
1.16
9.26
2.5
2.8
e6/l
3.9
4.8
2.18
1115
10003
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
909
7260
1.25
9.07
1.6
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
145
2399
0.59
9.07
1.8
1.7
mu/l
328.6
348.2
0.15
134
2148
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
192
2958
0.64
8.90
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
332
4577
0.71
8.69
1.7
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
152
890
1.69
8.63
1.5
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
601
7577
0.77
8.57
1.9
1.9
g/l
1.3
1.3
0.20
535
6862
(3024891) Influenza virus A+B Ag [Presence] in Specimen
392
2814
1.38
8.54
1.1
1.2
—
—
—
0
0
(4034850)
329
4525
0.71
8.50
11.4
9.5
—
—
—
0
0
(4010399)
850
10277
0.80
8.49
1.4
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
147
865
1.68
8.21
1.3
1.3
mmol/l
6.4
6.5
0.26
136
810
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
570
4359
1.30
8.14
1.8
1.9
ug/l
2.1
2.4
0.23
488
3809
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
264
3729
0.69
7.97
1.3
1.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
55
1162
0.46
7.74
1.3
1.5
—
2.1
—
0
11
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5335
56040
0.90
7.72
1.9
2.0
pmol/l
100.2
99.5
0.43
2432
25933
(3015736) pH of Urine
4741
50095
0.90
7.70
3.3
3.9
ph
5.6
5.9
—
7
15
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
146
875
1.65
7.64
1.5
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
4038
36749
1.11
7.62
2.8
3.1
e6/l
87.0
62.8
0.42
2988
27455
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
781
6259
1.24
7.60
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
155
945
1.62
7.59
1.1
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
494
6278
0.77
7.53
1.1
1.1
titre
390.0
206.0
—
7
143
(3026782) Osmolality of Urine
2669
23741
1.13
7.43
2.5
2.7
mosm/kgh2o
500.3
501.9
0.15
2272
19944
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
94
501
1.86
7.42
1.4
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
94
501
1.86
7.42
1.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
11630
111749
1.12
7.37
19.3
15.2
%
38.6
38.8
2.05
8217
77287
(3007164) IgA [Mass/volume] in Serum or Plasma
2322
25491
0.88
7.29
1.4
1.5
g/l
2.3
2.3
0.78
1130
14600
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2656
28902
0.89
7.23
1.6
1.7
pmol/l
38330640.5
35330057.5
0.09
2108
23544
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
331
2383
1.38
7.16
1.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
869
10294
0.82
7.12
2.0
2.3
ug/l
3.8
5.7
8.19
716
8736
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
186
1202
1.53
7.12
1.5
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1226
10341
1.18
7.06
2.9
4.2
%
0.4
0.1
7.04
466
2559
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
94
511
1.82
6.99
1.4
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
441
5628
0.77
6.97
1.5
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
48
205
2.31
6.86
1.1
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3757
34220
1.11
6.86
2.7
3.0
e6/l
0.5
0.4
1.33
2745
25357
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
178
1151
1.53
6.82
1.2
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
9792
99613
0.91
6.78
3.7
4.4
mm/h
14.2
13.3
6.77
8911
92055
(36304419) Bacteria [Presence] in Urine
3672
33441
1.11
6.69
2.7
3.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
318
4219
0.74
6.64
1.5
1.7
g/l
0.2
0.2
1.04
293
3980
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
78
1391
0.55
6.58
1.0
1.0
—
—
—
0
0
(3010421) pH of Blood
401
3015
1.32
6.56
3.1
3.3
ph
7.4
7.4
1.72
324
2511
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
330
4337
0.74
6.47
1.5
1.7
g/l
1.2
1.2
0.41
304
4113
(3029937) Albumin [Presence] in Urine by Test strip
3240
34645
0.90
6.35
4.0
4.6
estimate
0.0
0.0
2.76
1216
11476
(3031040) Bacteria [#/volume] in Urine by Automated count
9125
86852
1.09
6.33
4.7
4.9
e6/l
1103.1
2433.5
1.31
99
1038
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
314
0.22
6.25
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1162
9872
1.17
6.15
2.8
4.0
%
1.3
0.6
9.94
352
2003
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
606
4861
1.24
5.92
2.6
3.3
u/ml
1272.8
998.4
0.14
493
4083
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1092
12456
0.85
5.84
2.2
2.1
nmol/l
383.8
376.6
0.51
994
11373
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
171
1136
1.49
5.83
1.7
1.8
ug/l
18.3
25.2
1.70
165
1112
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
131
821
1.58
5.83
1.4
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
567
6854
0.81
5.72
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
148
2176
0.67
5.66
2.3
1.7
nmol/l
0.9
0.8
0.75
123
1793
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
329
4236
0.76
5.63
1.5
1.6
titre
87.7
261.6
4.97
11
218
(3009214) Lutropin [Units/volume] in Serum or Plasma
209
1454
1.42
5.63
1.2
1.2
u/l
23.9
22.4
0.62
173
1175
(3000919) Neutrophils/100 leukocytes in Pleural fluid
52
250
2.05
5.62
1.3
1.4
%
9.9
20.4
3.44
45
230
(3042733) HLA Ab [Presence] in Serum
6
278
0.21
5.60
4.5
5.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
111
1726
0.63
5.54
1.2
1.2
u/l
31.2
33.8
0.13
90
1502
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
347
4424
0.77
5.52
1.2
1.3
u/ml
9.8
43.4
6.55
13
292
(40761536) Microorganisms panel - Urine sediment
1222
10515
1.16
5.51
4.2
4.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
10293
104116
0.92
5.42
24.1
18.3
g/l
330.0
330.3
3.48
10245
103402
(3021879) Hepatitis B virus core Ab [Presence] in Serum
602
7178
0.82
5.33
1.2
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
2340
25249
0.90
5.33
1.7
1.8
nmol/l
1158.8
1196.5
1.11
1678
18824
(3024980) IgG subclass 4 [Mass/volume] in Serum
142
2078
0.67
5.33
1.3
1.5
g/l
0.6
0.6
0.09
96
1564
(21494755) Public health laboratory ask at order entry panel
742
8672
0.84
5.31
1.3
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
443
5452
0.79
5.29
1.4
1.5
u/ml
26.6
16.1
—
10
129
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
817
9453
0.84
5.22
2.4
2.4
au/ml
29.9
28.7
0.07
39
496
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
812
6797
1.19
5.17
4.5
6.1
mmol/l
25.2
25.1
0.19
800
6735
(3013727) Leukocytes other/100 leukocytes in Blood
68
370
1.82
5.16
1.8
3.8
%
49.5
52.3
0.38
63
361
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
440
5393
0.80
5.08
1.6
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
317
4042
0.77
5.08
1.2
1.3
u/ml
6.1
7.0
0.11
47
708
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
312
3983
0.77
5.05
1.2
1.3
u/ml
5.7
5.6
0.01
26
447
(3008757) Leukocyte morphology finding [Identifier] in Blood
187
1303
1.42
5.04
2.2
3.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
336
2568
1.30
4.98
3.4
3.5
mmol/l
2.5
2.8
0.91
242
1853
(3000330) Specific gravity of Urine by Test strip
581
6902
0.82
4.98
4.1
3.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
336
2569
1.30
4.97
3.4
3.5
kpa
5.0
5.1
0.81
323
2512
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
586
4781
1.22
4.93
1.4
1.4
pmol/l
119.2
166.9
2.66
573
4667
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
4676
43576
1.08
4.90
2.8
3.2
—
0.1
—
0
6
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
104
648
1.59
4.83
1.3
1.3
u/l
11.9
11.6
0.06
95
587
(3017354) Segmented neutrophils/100 leukocytes in Blood
174
1210
1.42
4.77
2.1
3.3
%
56.1
58.6
0.64
104
796
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
856
9790
0.85
4.76
1.2
1.2
iu/ml
171.6
147.7
0.95
343
3807
(3035880) pH of Pleural fluid
86
513
1.66
4.76
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
243
1789
1.34
4.72
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1179
13152
0.87
4.66
1.5
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
336
2596
1.28
4.62
3.4
3.5
kpa
8.6
8.6
0.40
323
2539
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
349
2712
1.28
4.58
2.8
3.2
u/ml
168.1
853.7
2.50
320
2448
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
242
1790
1.34
4.57
1.3
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
50
257
1.92
4.56
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
244
1808
1.34
4.56
1.3
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
58
1004
0.57
4.54
1.1
1.4
—
10512.0
—
0
5
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
49
889
0.54
4.53
1.4
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
257
3313
0.76
4.52
1.2
1.3
u/ml
27.0
47.9
2.53
25
390
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
21
74
2.80
4.52
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
52
272
1.89
4.51
1.4
1.3
%
1.3
3.1
1.88
44
228
(3005988) Vibrio sp identified in Specimen by Organism specific culture
242
1794
1.34
4.51
1.3
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
60
329
1.80
4.49
1.3
1.3
%
72.6
62.2
1.93
52
272
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1125
9774
1.15
4.47
1.5
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
748
8599
0.85
4.45
1.2
1.3
au/ml
57.7
50.7
0.26
31
360
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
59
1010
0.57
4.45
1.3
1.2
titre
212.0
184.5
—
10
170
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
812
6898
1.17
4.38
1.4
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
242
1805
1.33
4.34
1.3
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
263
3360
0.77
4.34
2.3
2.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
248
1858
1.32
4.32
1.8
1.8
mmol/l
1.7
1.7
0.66
243
1812
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
20
490
0.40
4.31
2.6
3.0
umol/l
26.8
28.0
0.18
15
367
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
191
2550
0.74
4.31
1.9
2.3
ug/min
40.3
70.1
1.30
92
1376
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
203
2684
0.74
4.29
1.3
1.5
e6/l
865.1
2100.0
1.40
150
2191
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
231
2996
0.76
4.27
1.3
1.3
miu/ml
252.5
217.6
0.74
108
1382
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
203
2680
0.74
4.25
1.3
1.4
e6/l
13.3
40.4
2.40
138
2073
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
78
1228
0.62
4.22
1.3
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
158
2166
0.72
4.22
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
51
892
0.56
4.18
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
276
3484
0.78
4.16
1.4
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
47
245
1.89
4.15
1.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
4965
46621
1.08
4.12
3.3
3.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3150
29058
1.09
4.12
1.6
1.7
mg/l
1.2
1.1
0.30
2422
22408
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4040
42065
0.93
4.04
2.3
2.5
u/l
57.3
58.1
0.31
3698
38376
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
297
3697
0.79
4.01
1.1
1.1
u/ml
1.8
8.6
5.75
37
384
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
245
1855
1.31
3.99
1.3
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
6976
66353
1.07
3.95
4.8
6.1
e9/l
0.2
0.2
12.66
5987
58023
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
34
659
0.51
3.95
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
4724
44342
1.07
3.92
3.3
3.6
e6/l
104.2
117.0
0.54
3211
30155
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
55
923
0.59
3.90
2.2
2.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
83
1263
0.65
3.89
1.5
1.5
%
33.5
33.8
0.02
46
733
(40768797) Stomach Pathology biopsy report
1883
20227
0.91
3.88
1.2
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
94
605
1.54
3.87
1.6
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
312
2448
1.26
3.85
2.3
2.4
%
15.9
16.0
0.05
138
1223
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
264
3313
0.78
3.83
1.2
1.3
u/ml
1.0
5.2
2.82
14
268
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
44
231
1.88
3.83
1.3
1.3
ug/l
636.4
224.9
0.52
36
137
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
30
137
2.16
3.81
1.4
1.3
%
9.6
15.1
0.88
18
66
(3003327) Ova and parasites identified in Stool by Light microscopy
380
4573
0.81
3.79
1.6
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
95
617
1.52
3.77
1.7
1.4
—
—
—
0
0
(3000492) Spirometry study
1038
11507
0.88
3.76
1.5
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
92
1359
0.67
3.75
1.1
1.1
—
1.7
—
0
26
(3000475) Leukocytes [#/volume] in Synovial fluid
273
3395
0.79
3.69
1.6
1.7
e6/l
17575.6
11079.7
1.01
193
2462
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
18
425
0.42
3.61
1.4
1.7
ug/l
9.1
8.7
0.18
18
425
(40768443) Skin Pathology biopsy report
739
6337
1.16
3.59
1.2
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
94
1358
0.68
3.46
1.2
1.4
g/l
6.8
6.7
0.08
57
959
(3024139) IgG subclass 3 [Mass/volume] in Serum
94
1357
0.68
3.44
1.2
1.4
g/l
0.4
0.4
0.23
57
958
(3028192) IgG subclass 2 [Mass/volume] in Serum
94
1357
0.68
3.44
1.2
1.4
g/l
2.8
2.8
0.09
57
957
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
425
3496
1.20
3.41
1.8
2.0
%
96.3
94.8
0.68
374
3213
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
255
1986
1.27
3.40
1.4
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
110
1533
0.71
3.33
1.1
1.1
iu/ml
59.9
8049.6
0.55
31
297
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
148
1965
0.74
3.32
1.1
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
71
1075
0.65
3.31
1.3
1.3
u/ml
4.2
1.1
0.40
24
510
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
128
1736
0.72
3.29
1.5
1.6
%
55.0
54.1
0.10
82
1056
(3025159) Blasts/100 leukocytes in Blood
1109
9830
1.12
3.28
3.0
4.2
%
0.6
0.3
0.50
384
2205
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
149
1972
0.74
3.27
1.1
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
368
4371
0.83
3.27
1.4
1.4
ug/g
277.7
280.6
0.10
229
2500
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
986
10864
0.89
3.26
1.5
1.6
%
1.4
1.4
0.05
849
9402
(40763480) Human metapneumovirus Ag [Presence] in Specimen
15
53
2.79
3.26
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1608
17257
0.91
3.25
6.8
6.7
—
—
—
0
0
(4062490)
95
1351
0.69
3.24
1.2
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
100
680
1.45
3.23
1.6
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
154
2022
0.75
3.21
1.3
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
6860
65491
1.06
3.19
4.8
6.0
e9/l
1.7
1.9
30.34
5899
57446
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
194
1473
1.30
3.18
1.4
1.4
—
—
—
0
0
(44790048)
158
1168
1.34
3.13
1.2
1.5
—
—
—
0
0
(44806118)
158
1168
1.34
3.13
1.2
1.5
—
—
—
0
0
(44790049)
158
1168
1.34
3.13
1.2
1.5
—
—
—
0
0
(44790047)
158
1168
1.34
3.13
1.2
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
308
3703
0.82
3.12
1.2
1.2
titre
635.7
975.0
0.90
14
167
(1001926) Buprenorphine [Presence] in Urine by Screen method
102
1420
0.71
3.10
1.6
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
73
1081
0.66
3.09
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
132
1759
0.74
3.06
1.2
1.3
u/ml
120.8
120.9
0.01
29
421
(3020779) Urea [Moles/volume] in Serum or Plasma
842
9314
0.88
3.00
4.7
6.4
mmol/l
8.5
9.3
3.01
802
8833
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
287
3458
0.81
2.98
1.2
1.5
iu/ml
9.5
20.3
—
7
97
(3048929) Epstein Barr virus Ab [Presence] in Serum
209
2607
0.79
2.98
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
132
1750
0.74
2.97
1.1
1.2
u/ml
266.9
297.1
0.50
79
1098
(3027944) Amphetamines [Presence] in Urine
139
1826
0.75
2.94
1.6
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
90
1266
0.70
2.93
1.4
1.5
e6/l
233667.9
110891.4
0.68
57
857
(3016650) Hepatitis A virus Ab [Presence] in Serum
140
1833
0.75
2.90
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
699
7802
0.88
2.88
2.4
2.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
47
753
0.61
2.87
2.2
2.4
e9/l
0.2
0.2
0.05
42
659
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
31
161
1.90
2.86
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
829
9147
0.89
2.84
3.4
3.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
26
487
0.53
2.82
1.7
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
78
521
1.48
2.81
1.1
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
76
506
1.48
2.78
1.1
1.1
%
101.7
95.8
1.21
63
382
(3039162) Centromere protein B Ab [Units/volume] in Serum
159
2032
0.77
2.78
1.2
1.3
u/ml
75.0
59.5
—
8
162
(3041096) Erythrocytes [Presence] in Urine by Automated
3219
33394
0.94
2.76
3.7
3.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
61
907
0.66
2.69
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
94
1289
0.72
2.67
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
178
2228
0.79
2.65
1.4
1.3
nmol/l
0.2
0.2
—
9
145
(3014599) Egg white IgE Ab [Units/volume] in Serum
36
602
0.59
2.64
1.1
1.0
u/ml
0.5
0.9
—
8
142
(3008401) Mugwort IgE Ab [Units/volume] in Serum
122
1604
0.75
2.64
1.1
1.1
u/ml
1.6
0.8
0.30
44
580
(3021788) Differential panel - Synovial fluid
209
2566
0.80
2.64
1.4
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
146
1871
0.77
2.63
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
128
1669
0.75
2.62
1.1
1.1
u/ml
2.9
2.8
0.04
50
709
(3014148) Varicella zoster virus Ab [Titer] in Serum
87
1204
0.71
2.62
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
148
1892
0.77
2.62
1.3
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
4121
42365
0.94
2.61
2.7
3.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
61
900
0.67
2.60
1.2
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
57
363
1.55
2.59
1.1
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
131
1698
0.76
2.57
1.6
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
226
1802
1.24
2.56
1.8
1.7
u/l
774.6
2575.0
1.63
74
680
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
153
1940
0.78
2.55
1.4
1.2
nmol/l
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
53
801
0.65
2.55
1.6
1.5
u/l
6.0
5.3
0.43
43
670
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
29
154
1.86
2.54
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
13
298
0.43
2.53
1.5
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
298
0.43
2.53
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3558
36687
0.94
2.48
1.6
1.7
mmol/l
1.4
1.3
0.65
2919
30567
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
35
577
0.60
2.46
1.2
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
995
10770
0.90
2.44
2.4
2.8
ng/l
163.6
177.0
0.66
906
9871
(3007566) Smooth muscle Ab [Titer] in Serum
313
3660
0.84
2.44
1.2
1.2
titre
113.9
153.2
0.37
28
296
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
201
1592
1.25
2.44
1.4
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
180
2223
0.80
2.43
1.4
1.3
nmol/l
5.2
1.3
0.39
174
2135
(3004716) Salmonella sp identified in Stool by Organism specific culture
578
6450
0.88
2.43
1.4
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
14
306
0.45
2.42
1.1
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
700
7709
0.89
2.38
4.1
4.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
59
857
0.68
2.36
1.6
2.3
ml
644.5
638.4
0.04
35
596
(3028300) Cannabinoids [Presence] in Urine
149
1864
0.79
2.27
1.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
1461
15484
0.92
2.26
1.3
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
378
3205
1.17
2.26
2.0
2.3
g/l
3.5
3.6
1.18
365
3046
(3020874) Milk IgE Ab [Units/volume] in Serum
40
623
0.63
2.25
1.1
1.0
u/ml
0.4
1.1
0.78
12
184
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
362
0.52
2.24
1.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
211
1698
1.23
2.24
1.4
1.4
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
59
0.00
2.24
0.0
1.2
—
1.7
—
0
47
(3006315) Basophils [#/volume] in Blood
6694
64266
1.05
2.24
4.7
5.9
e9/l
0.0
0.0
3.27
5679
55276
(3045414) Leukocytes [Presence] in Urine
585
6483
0.89
2.23
1.9
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
238
2823
0.83
2.21
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
149
1857
0.79
2.21
1.5
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
42
643
0.64
2.19
1.5
2.2
min
512.9
499.8
0.39
26
490
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
54
785
0.68
2.19
2.1
2.3
e6/l
477.4
537.2
0.29
43
663
(3037692) Legionella sp identified in Specimen by Organism specific culture
61
411
1.47
2.18
1.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
149
1851
0.79
2.16
1.5
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
45
676
0.66
2.16
1.3
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
91
1206
0.74
2.15
1.1
1.1
u/ml
1.6
3.1
1.57
30
433
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
76
1034
0.72
2.13
1.1
1.0
u/ml
0.1
0.5
1.25
15
198
(4094501)
311
3589
0.85
2.12
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
14
288
0.48
2.10
1.4
2.0
e6/l
3608.3
209.7
—
6
165
(3023183) Ammonium ion [Moles/volume] in Plasma
246
2026
1.20
2.10
2.0
2.6
umol/l
37.8
32.9
1.67
198
1720
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
151
1864
0.80
2.08
1.1
1.1
u/ml
1.8
1.1
0.35
53
630
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
48
311
1.52
2.08
1.2
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
20
101
1.95
2.07
2.6
2.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
6654
63960
1.05
2.06
4.7
5.9
e9/l
0.5
0.6
4.36
5647
55044
(1002224) Polysomnography panel
395
4465
0.87
2.06
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
258
0.46
2.04
1.3
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
154
1890
0.80
2.03
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
64
887
0.71
2.02
1.8
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
168
2042
0.81
2.02
1.4
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4794
48809
0.95
2.02
3.3
3.5
ng/l
29.9
56.2
1.53
3387
32187
(3026470) Cobalt [Mass/volume] in Blood
58
817
0.70
2.02
2.0
2.1
ug/l
4.2
4.1
0.07
51
724
(3010726) Horse dander IgE Ab [Units/volume] in Serum
115
1460
0.77
2.01
1.1
1.1
u/ml
1.1
1.1
0.05
26
295
(40760888) Immunoglobulin light chains.free panel - Serum
262
3050
0.84
2.01
3.3
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
228
2686
0.83
2.00
1.8
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
286
3304
0.85
2.00
1.8
1.7
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
56
792
0.70
1.99
2.0
2.1
ug/l
3.0
2.8
0.13
46
674
(3014133) Dog dander IgE Ab [Units/volume] in Serum
100
1290
0.76
1.98
1.0
1.1
u/ml
3.1
3.2
0.03
31
432
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
383
3289
1.15
1.98
2.5
2.2
%
192.6
191.8
0.05
365
3081
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
260
3023
0.85
1.97
1.3
1.3
mg/l
540.6
539.1
0.01
246
2875
(3046861) Legionella sp Ag [Presence] in Urine
12
50
2.37
1.96
1.3
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
43
637
0.66
1.96
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
43
636
0.67
1.94
1.3
1.4
—
—
—
0
0
(4281824)
264
2207
1.18
1.93
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
130
1010
1.27
1.93
5.6
6.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
43
635
0.67
1.93
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
43
635
0.67
1.93
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
87
640
1.34
1.92
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
87
640
1.34
1.92
1.2
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
136
1064
1.26
1.91
2.2
2.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
319
3639
0.86
1.91
3.0
4.0
mmol/l
3.8
3.8
0.45
302
3445
(3006653) Thiamine [Moles/volume] in Blood
39
586
0.66
1.91
1.2
1.3
nmol/l
127.7
134.5
0.63
39
586
(3009466) Valproate [Moles/volume] in Serum or Plasma
127
1579
0.79
1.90
5.2
5.0
umol/l
362.9
375.7
0.43
107
1372
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
151
1200
1.24
1.86
1.1
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
47
312
1.49
1.85
1.2
1.1
—
—
—
0
0
(3036489) Thrombin time
504
4432
1.13
1.84
1.8
1.8
s
22.0
21.4
0.59
430
3842
(3013166) Neutrophils/100 leukocytes in Synovial fluid
24
400
0.59
1.84
1.5
1.5
%
44.1
50.8
0.35
16
338
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
201
1649
1.20
1.83
1.1
1.1
%
125.0
124.9
0.02
183
1465
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2287
21456
1.06
1.82
2.4
2.6
e6/l
2.9
1.4
0.55
1171
12058
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
56
777
0.71
1.82
2.0
2.5
e6/l
502.3
844.4
1.62
26
348
(3024263) Appearance of Synovial fluid
48
684
0.69
1.81
1.4
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
179
0.44
1.80
17.9
8.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
71
512
1.37
1.80
2.5
2.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
121
1.79
1.80
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
182
0.43
1.79
2.1
1.9
umol/l
13.5
17.9
—
8
182
(3014891) Appearance of Pleural fluid
23
129
1.76
1.77
1.4
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
31
480
0.64
1.77
1.1
1.1
miu/ml
1054.5
1586.0
2.49
31
480
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
42
276
1.50
1.75
1.2
1.1
pmol/l
2.7
2.9
—
5
36
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
24
394
0.60
1.75
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
30
466
0.63
1.74
2.6
2.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
59
803
0.72
1.72
1.3
1.5
umol/l
7.5
8.8
0.14
41
577
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
11
47
2.31
1.72
1.1
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
349
3920
0.87
1.72
3.0
3.4
ratio
4.1
4.5
0.04
16
304
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
20
342
0.58
1.71
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
20
342
0.58
1.71
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
20
342
0.58
1.71
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
20
342
0.58
1.71
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
40
262
1.51
1.70
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
153
1837
0.82
1.69
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
21
353
0.59
1.69
1.3
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7331
73727
0.96
1.66
2.6
2.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
510
5584
0.90
1.66
1.9
2.0
u/l
41.9
40.2
1.15
454
4914
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
54
379
1.41
1.63
1.3
1.7
e6/l
2252.7
15738.3
1.43
28
179
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
40
576
0.68
1.63
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
39
564
0.68
1.63
1.4
1.4
nmol/l
2.0
1.1
0.44
30
431
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
91
695
1.29
1.60
1.1
1.1
ratio
1.0
1.1
1.96
59
242
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
33
491
0.66
1.59
1.3
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
364
4052
0.88
1.58
3.0
3.5
mg/l
47.4
79.4
0.77
287
3303
(3002523) Influenza virus A Ag [Presence] in Specimen
174
1432
1.20
1.58
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
174
1432
1.20
1.58
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
99
1235
0.79
1.58
2.3
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
98
1224
0.79
1.58
2.0
2.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
32
478
0.66
1.58
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
469
5142
0.90
1.58
1.4
1.7
g/l
1.7
1.6
1.05
380
4370
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
46
641
0.71
1.57
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
321
2776
1.14
1.57
2.0
2.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
19
320
0.58
1.56
1.1
1.0
u/ml
0.5
0.8
—
10
158
(3043238) Trisomy 21 risk [Likelihood] in Fetus
39
558
0.69
1.55
1.3
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
50
350
1.41
1.55
1.2
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
109
856
1.26
1.55
1.3
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
74
955
0.76
1.55
1.6
2.0
g/24h
0.3
0.6
—
5
38
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
27
166
1.60
1.53
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
127
1533
0.82
1.52
2.4
2.7
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
25
151
1.63
1.52
1.3
1.2
mmol/l
2.9
2.0
0.15
16
94
(3028433) Virus identified in Specimen by Culture
57
410
1.37
1.51
1.1
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
140
0.42
1.51
1.3
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
364
4036
0.89
1.50
3.0
3.5
mg/l
36.6
40.7
0.22
285
3286
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
934
9890
0.93
1.49
3.1
3.2
pmol/l
4.5
4.4
1.03
831
8666
(36033641